| Serial Number | 87777607 |
| Word Mark | ENGENSIS |
| Filing Date | Wednesday, January 31, 2018 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Monday, June 9, 2025 |
| Registration Number | 5694789 |
| Registration Date | Tuesday, March 12, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 2, 2018 |
| Goods and Services | Chemical reagents for use in veterinary genetic testing; reagents for use in medical genetic testing; diagnostic preparations for medical purposes for detecting mutation in prion genes; preparations for medical purposes for detecting mutation in prion genes; chemical preparations for pharmaceutical purposes, namely, for painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; drugs for medical purposes, namely, prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; medicines for human purposes, namely, pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; pharmaceutical preparations for diagnosis of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; ethical medicinal preparations, namely, pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical preparations for use in medical DNA analysis; genetic treatment pharmaceutical preparations |
| Goods and Services | Pharmaceutical research and development; pharmaceutical research services; consultancy relating to pharmaceutical research and development; research and development of vaccines and medicines; scientific research in the fields of biomedicine; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine, health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 9, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 9, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | HELIXMITH CO., LTD |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | SEOUL 08826 KR |
| Party Name | ViroMed Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Gwanak-gu, Seoul KR |
| Party Name | ViroMed Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Gwanak-gu, Seoul KR |
| Party Name | ViroMed Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Gwanak-gu, Seoul KR |
| Event Date | Event Description |
| Tuesday, May 1, 2018 | ASSIGNED TO LIE |
| Saturday, February 3, 2018 | NEW APPLICATION ENTERED |
| Friday, February 9, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 24, 2018 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, May 1, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 1, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 14, 2018 | ASSIGNED TO EXAMINER |
| Monday, May 14, 2018 | NON-FINAL ACTION WRITTEN |
| Monday, May 14, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, May 14, 2018 | NON-FINAL ACTION E-MAILED |
| Thursday, August 23, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 23, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 23, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 24, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 2, 2018 | PUBLISHED FOR OPPOSITION |
| Friday, December 21, 2018 | TEAS DELETE 1(B) BASIS RECEIVED |
| Friday, December 21, 2018 | NOTICE OF ALLOWANCE CANCELLED |
| Wednesday, September 12, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 2, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 27, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 5, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, February 5, 2019 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Tuesday, March 12, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Friday, May 10, 2019 | REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED |
| Wednesday, June 19, 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, March 12, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Thursday, February 13, 2025 | TEAS SECTION 8 & 15 RECEIVED |
| Monday, June 9, 2025 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, June 9, 2025 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Monday, June 9, 2025 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |